Literature DB >> 2506191

Adenosine triphosphate, bradykinin, and thyrotropin-releasing hormone regulate the intracellular Ca2+ concentration and the 45Ca2+ efflux of human thyrocytes in primary culture.

E Raspé1, G Andry, J E Dumont.   

Abstract

The hormonal stimulation of phospholipase C and the consequent activation of the Ca2+-phosphatidylinositol cascade in eukaryotic cells is associated with modifications of the [Ca2+]i (intracellular Ca2+ concentration) which modulates cellular functions. In this study, these modifications were investigated in primary cultures of human thyroid cells. The mean apparent basal [Ca2+]i of human thyrocytes measured using the intracellularly trapped fluorescent indicator Quin-2 was found to be 89 +/- 16 nM (n = 49). ATP and, to a lesser extent, ADP, but not AMP or adenosine, elicited a concentration-dependent biphasic rise in human thyrocytes [Ca2+]i and increased their 45Ca2+ efflux. The first transient phase of the [Ca2+]i rise induced by ATP was resistant to extracellular Ca2+ depletion, whereas the second sustained phase was abolished in these conditions. This suggests that although the first phase of this response involves a release of Ca2+ from intracellular stores, the second phase requires extracellular Ca2+ influx. The response of human thyrocytes to analogs of ATP is compatible with a P2-purinergic effect of ATP on these cells. Bradykinin and TRH affected the human thyrocyte [Ca2+]i and 45Ca2+ efflux similarly to ATP. The human thyrocyte [Ca2+]i and the 45Ca2+ efflux were not modified by carbachol, a nonhydrolyzable analog of acetylcholine. The present results suggest the presence of P2-purinergic receptors to ATP and of receptors to TRH and bradykinin on human follicular thyroid cells. They also confirm that the Ca2+-phosphatidylinositol cascade is present in these cells and suggest that this cascade is modulated by ATP, TRH, and bradykinin. As this cascade is involved in the regulation of protein iodination, and therefore of thyroid hormones synthesis, these agents might have an important role in the regulation of the thyroid function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506191     DOI: 10.1002/jcp.1041400328

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid.

Authors:  R Glass; G Burnstock
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

2.  Role of P2-purinergic receptors in rat Leydig cell steroidogenesis.

Authors:  C Foresta; M Rossato; A Nogara; F Gottardello; P Bordon; F Di Virgilio
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

3.  HLA-DMB expression by thyrocytes: indication of the antigen-processing and possible presenting capability of thyroid cells.

Authors:  Z Wu; P A Biro; R Mirakian; L Hammond; F Curcio; F S Ambesi-Impiombato; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

4.  Long-term culture and functional characterization of follicular cells from adult normal human thyroids.

Authors:  F Curcio; F S Ambesi-Impiombato; G Perrella; H G Coon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  ATP activates a Ca(2+)-dependent Cl- current in the rat thyroid cell line, FRTL-5.

Authors:  S C Martin
Journal:  J Membr Biol       Date:  1992-02       Impact factor: 1.843

6.  UTP-preferring P2 receptor mediates inhibition of sodium transport in porcine thyroid epithelial cells.

Authors:  J Bourke; K Abel; G Huxham; V Cooper; S Manley
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

7.  P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells.

Authors:  W G Fang; F Pirnia; Y J Bang; C E Myers; J B Trepel
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 8.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.